← Leaderboards
Holger A. Russ
University Of Colorado Denver
$4,868,284
Attributed
$7,800,360
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,800,360 · 7
By mechanism
R01$5,367,847 · 3
UG3$1,207,770 · 1
P30$797,118 · 2
R21$427,625 · 1
Top collaborators
- Edward Phelps7 shared
- Jefferson Matthew Taliaferro3 shared
- Howard W Davidson2 shared
- Remi J Creusot1 shared
- Megan Sykes1 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Marian J. Rewers$53,889,410
- George S Eisenbarth$13,354,570
- Maki Nakayama$6,654,561
- Jill M Norris$16,405,166
- Aaron W Michels$8,254,447
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsBeta CellDiabetes MellitusStem CellsInsulin-Dependent Diabetes MellitusTransplantationGenome EngineeringGenerationsIsletIn VitroInsulinExperimental StudySourceGenesPreventImmunotherapyCadaverPre-ClinicalAutomobile DrivingAnimal ModelInnovationBeta Cell ReplacementCell TransplantationHumanized Mouse
Grant awards (21)
Understanding thymic epithelial and hematopoietic stem cell-intrinsic immune abnormalities driving T1D in optimized HIS mouse models$1,207,770
UG3 · FY2025 · DK
Mechanistic analysis of TDP-43-mediated RNA localization in neurons and its misregulation in ALS$579,252
R01 · FY2025 · NS
Local immune modulation for beta cell replacement therapy in type 1 diabetes$484,597
R01 · FY2025 · DK
Mechanistic analysis of TDP-43-mediated RNA localization in neurons and its misregulation in ALS$561,876
R01 · FY2024 · NS
Local immune modulation for beta cell replacement therapy in type 1 diabetes$466,338
R01 · FY2024 · DK
Disease Modeling Core$169,352
P30 · FY2024 · DK · contact PI
Local immune modulation for beta cell replacement therapy in type 1 diabetes$25,293
R01 · FY2024 · DK
Mechanistic analysis of TDP-43-mediated RNA localization in neurons and its misregulation in ALS$593,252
R01 · FY2023 · NS
Local immune modulation for beta cell replacement therapy in type 1 diabetes$487,263
R01 · FY2023 · DK
Disease Modeling Core$173,857
P30 · FY2023 · DK · contact PI
Local immune modulation for beta cell replacement therapy in type 1 diabetes$75,883
R01 · FY2023 · DK
Local immune modulation for beta cell replacement therapy in type 1 diabetes$501,826
R01 · FY2022 · DK
Local immune modulation for beta cell replacement therapy in type 1 diabetes$50,587
R01 · FY2022 · DK
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.$385,420
R01 · FY2021 · DK · contact PI
Disease Modeling Core$182,477
P30 · FY2021 · DK · contact PI
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.$385,420
R01 · FY2020 · DK · contact PI
Disease Modeling Core$271,432
P30 · FY2020 · DK · contact PI
Stress induced changes to the human beta cell proteome$194,375
R21 · FY2020 · AI
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.$385,420
R01 · FY2019 · DK · contact PI
Stress induced changes to the human beta cell proteome$233,250
R21 · FY2019 · AI
Improving human pluripotent stem cell derived beta cell transplantation using genetic lineage tracing.$385,420
R01 · FY2018 · DK · contact PI